We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Lateral Flow Assay Detects Several Viral Fevers Simultaneously

By LabMedica International staff writers
Posted on 10 Mar 2015
Print article
Image: The diagnostic system is based on triangular silver nanoparticles that display different colors depending on their size (Photo courtesy of the Massachusetts Institute of Technology).
Image: The diagnostic system is based on triangular silver nanoparticles that display different colors depending on their size (Photo courtesy of the Massachusetts Institute of Technology).
A team of biomedical engineers has developed a rapid diagnostic test that is able to detect several viruses such as Ebola, dengue fever, and yellow fever simultaneously from a single sample of patient's serum.

Investigators at the Massachusetts Institute of Technology (Cambridge, MA, USA) and Harvard Medical School (Boston, MA, USA) used a novel class of silver nanoparticles to drive a paper-based lateral flow assay. Lateral flow assays are commonly used to detect such pathogens as Rotavirus, adenovirus, Streptococcus A and B, and gonorrhea and in rapid pregnancy tests.

The investigators extended the usefulness of the lateral flow approach by incorporating antibodies bound to different colored nanoparticles. In the current version of the assay, following a 10 minute incubation, an orange band indicates the presence of yellow fever virus, a red band indicates Ebolavirus, and a green band indicates dengue fever virus.

The investigators expect that their new rapid test will complement more definitive diagnostic technologies, such as PCR. "If you are in a situation in the field with no power and no special technologies, if you want to know if a patient has Ebola, this test can tell you very quickly that you might not want to put that patient in a waiting room with other people who might not be infected," said senior author Dr. Lee Gehrke, professor of microbiology and immunology at Harvard Medical School. "That initial triage can be very important from a public health standpoint, and there could be a follow-up test later with PCR or something to confirm."

This type of diagnostic testing device is readily customizable to detect other infectious diseases, by linking the silver nanoparticles to different antibodies. "Thankfully the Ebola outbreak is dying off, which is a good thing, but what we are thinking about is what is coming next," said Dr. Gehrke. "There will undoubtedly be other viral outbreaks. It might be Sudan virus, or it might be another hemorrhagic fever. What we are trying to do is develop the antibodies needed to be ready for the next outbreak that is going to happen."

The rapid diagnostic test for multiple viral fevers was described in the February 12, 2015, online edition of the journal Lab on a Chip.

Related Links:
Massachusetts Institute of Technology
Harvard Medical School


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.